
Innova Captab IPO
- Issue price
- ₹448
- Listing price
- ₹452.1
- +0.92%
- Current price
- ₹1,172.4
- +161.70%
- Subscribed
- 56.33x
- Issue size
- ₹570 Cr
- Listed on
- 29 Dec 2023
IPO timeline
- Opens21 DecThu
- Closes26 DecTue
- Allotment27 DecWed
- Refunds28 DecThu
- Demat credit28 DecThu
- Listing29 DecFri
Issue details
- Price band
- ₹426 – ₹448 per share
- Issue size
- ₹570 Cr
- Fresh issue
- Not available
- Offer for sale
- Not available
- Issue type
- Fresh capital cum OFS
- Face value
- ₹10 per share
- Lot size
- 33 shares
- Minimum investment
- ₹14,784
- Listing on
- BSE, NSE
- Exchange code
- INNOVACAP · 544067
This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,784 |
| Retail (Max) | 13 | 429 | ₹1,92,192 |
| S-HNI (Min) | 14 | 462 | ₹2,06,976 |
| B-HNI (Min) | 68 | 2,244 | ₹10,05,312 |
Reservation
- QIB
- 63,61,606 shares (50.00% of the Offer)
- NII
- 19,08,483 shares (15.00% of the Offer)
- Retail
- 44,53,125 shares (35.00% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on KFin Technologies- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 27 Dec 2023
- Refunds initiated
- 28 Dec 2023
- Shares credited to demat
- 28 Dec 2023
- Listing
- 29 Dec 2023
Grey market premium (GMP)
- Current GMP
- ₹70
- +16.00%
- Estimated listing price
- ₹518
- Issue price ₹448
- Highest
- ₹210
- 19 Dec
- Lowest
- ₹70
- 28 Dec
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 28 Dec 2023 | ₹70 | +16.00% | ₹518 |
| 27 Dec 2023 | ₹120 | +27.00% | ₹568 |
| 26 Dec 2023 | ₹130 | +29.00% | ₹578 |
| 23 Dec 2023 | ₹100 | +22.00% | ₹548 |
| 22 Dec 2023 | ₹100 | +22.00% | ₹548 |
| 21 Dec 2023 | ₹150 | +33.00% | ₹598 |
| 20 Dec 2023 | ₹210 | +47.00% | ₹658 |
| 19 Dec 2023 | ₹210 | +47.00% | ₹658 |
| 18 Dec 2023 | ₹200 | +45.00% | ₹648 |
- Kostak rate
- ₹0
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB116.15x
- NII (HNI)66.83x
- Retail17.64x
Financials
- P/E Ratio
- 36.42
- RoE
- 24.58%
- RoCE
- 22.61%
- RoNW
- 24.58%
- PAT Margin
- 7.34%
- Debt / Equity
- 0.85
- NAV (₹)
- 57.60
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 1,086.16 | 704.41 | 575.48 | 369.62 |
| Total Income | 234.37 | 935.58 | 803.41 | 412.03 |
| Profit After Tax | 17.59 | 67.95 | 63.95 | 34.50 |
| NET Worth | 365.51 | 276.51 | 208.61 | 144.82 |
| Reserves and Surplus | 317.51 | 228.51 | 196.61 | 132.82 |
| Total Borrowing | 441.90 | 235.19 | 198.18 | 45.03 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Innova Captab This IPO | ₹570 Cr | 36.42 | 24.58% | 7.34% | 56.33x | +0.92% |
| Senores Pharmaceuticals Mainboard · listed 30 Dec 2024 | ₹582.11 Cr | 28.21 | 23.60% | 15.25% | 96.96x | +53.45% |
| GPT Healthcare Mainboard · listed 29 Feb 2024 | ₹525.14 Cr | 32.49 | 23.77% | 10.64% | 8.52x | +15.59% |
| Gandhar Oil Refinery (India) Mainboard · listed 30 Nov 2023 | ₹500.69 Cr | 7.62 | 32.28% | 5.20% | 65.63x | +76.33% |
| Corona Remedies Mainboard · listed 15 Dec 2025 | ₹655.37 Cr | 58.26 | 24.65% | 12.49-13.33% | 137.04x | +38.42% |
| Sahajanand Medical Technologies Mainboard · listed 23 Oct 2026 | ₹475.48 Cr | 57.91 | 2.31% | 4.29% | 14.2x | +7.89% |
| Fusion CX Mainboard · listed 22 Oct 2026 | ₹702 Cr | 18.73 | 9.12% | 11.36% | 4.45x | +5.54% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Innova Captab plans to use the money raised, as stated in the offer document.
- Repayment and/or prepayment, in part or in full, of certain outstandingloans of the Company₹144.4 Cr
- Investment in our Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML₹23.6 Cr
- Funding the working capital requirements₹72 Cr
- General corporate purposes₹53.11 Cr
About Innova Captab
Innova Captab Limited was incorporated as Harun Health Care Private Limited in Mumbai on 3 January 2005. It is an integrated pharmaceutical company with a presence across research and development, manufacturing, distribution, marketing and exports. Its business has three parts: a CDMO business giving research, development and manufacturing services to Indian pharmaceutical companies, a domestic branded generics business and an international branded generics business. As per CRISIL, in Fiscal 2022 it had the third highest operating revenue and the second highest operating margin among Indian formulation CDMO players covered in the report. The IPO was Rs 570 crore, with Rs 320.00 crore of fresh issue and Rs 250.00 crore of offer for sale by the two promoters and another shareholder. Rs 144.40 crore was planned for repaying borrowings and Rs 72.00 crore for working capital.
Strengths
- Total income rose from Rs 412.03 crore in FY2021 to Rs 935.58 crore in FY2023.
- Profit after tax rose from Rs 34.50 crore in FY2021 to Rs 67.95 crore in FY2023.
- It had the 3rd highest operating revenue among Indian formulation CDMO players in Fiscal 2022, as per CRISIL.
- Rs 144.40 crore of the fresh issue was planned for repaying debt.
- The source puts return on net worth at 24.58%.
Risks
- Total borrowing rose from Rs 45.03 crore on 31 March 2021 to Rs 441.90 crore on 30 June 2023.
- Margins are thin, and the source puts the PAT margin at 7.34%.
- The pre-issue P/E was 31.64 at the upper band of Rs 448, as per the source.
- Profit was Rs 17.59 crore in the three months to 30 June 2023, and growth slowed in FY2023 to Rs 67.95 crore.
- Promoters and the promoter group held 66.85% before the issue and about 51.68% after it, as per the RHP share counts.
Promoters and shareholding
Manoj Kumar Lohariwala and Vinay Kumar Lohariwala
- Promoter holding, pre-issue
- 66.85%
- Promoter holding, post-issue
- 51.68%
Anchor investors
Registrar, lead managers and documents
Lead managers
Documents
Innova Captab IPO: common questions
1.When does the Innova Captab IPO open and close?
The Innova Captab IPO opens on 21 Dec 2023 and closes on 26 Dec 2023.
2.What is the price band of the Innova Captab IPO?
The price band is ₹426 – ₹448 per share, with a lot size of 33 shares and a minimum investment of ₹14,784.
3.What is the size of the Innova Captab IPO?
The issue size is ₹570 Cr (Fresh capital cum OFS).
4.What is the GMP of the Innova Captab IPO?
The last reported grey market premium is ₹70 per share as of 28 Dec 2023, 12:00 PM IST. GMP is unofficial and changes frequently.
5.When is the Innova Captab IPO allotment?
The basis of allotment is expected on 27 Dec 2023. Allotment status can be checked with the registrar, KFin Technologies Limited.
6.When will the Innova Captab IPO list?
The shares listed on 29 Dec 2023 on BSE, NSE.
7.Who is the lead manager of the Innova Captab IPO?
The book running lead managers are JM Financial Ltd., ICICI Securities, and the registrar is KFin Technologies Limited.
8.What will the money raised in the Innova Captab IPO be used for?
As stated in the offer document, the proceeds are for: Repayment and/or prepayment, in part or in full, of certain outstandingloans of the Company; Investment in our Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML; Funding the working capital requirements; General corporate purposes.
9.How can my company launch an IPO like Innova Captab?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393